Stock ORGANOVO HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Organovo Holdings Inc Nyse

Equities

US68620A1043

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Organovo Holdings Inc
Apr. 15 Organovo's fatty liver disease drug meets main goal in mid-stage study RE
Apr. 15 Organovo Holdings, Inc. Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ONVO Stock
  4. Stock
  5. News Organovo Holdings Inc
  6. MarketScreener Strategies